p53-dependent BRCA1 nuclear export controls cellular susceptibility to DNA damage

Juhong Jiang, Eddy S. Yang, Guochun Jiang, Somaira Nowsheen, Hong Wang, Tong Wang, Yihan Wang, David D Billheimer, A. Bapsi Chakravarthy, Melissa Brown, Bruce Haffty, Fen Xia

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Subcellular localization regulates BRCA1 function, and BRCA1 is exported to the cytoplasm following DNA damage in a p53-dependent manner. Because more than 50% of solid tumors harbor p53 mutations, it is possible that genetically wild-type (wt) BRCA1 is functionally abnormal through compromised nuclear-cytoplasmic shuttling in sporadic breast cancer patients with dysfunctional p53. In this study, we have investigated the mechanisms of p53-dependent BRCA1 subcellular distribution and DNA damage-induced nuclear export, as well as the impact on the resulting cytotoxic response to therapy in human breast cancer. We first show that p53 mediates BRCA1 nuclear export via protein - protein binding, rather than by modulation of its transcription. Furthermore, it is the C-terminal (BRCT) region of BRCA1 that is critical for its interaction with p53, and p53 may promote BRCA1 nuclear export by interrupting the association of BRCA1 with BARD1. In sporadic breast cancer specimens, dysfunctional p53 strongly correlates with nuclear retention of sequence-verified wt BRCA1. This p53-dependent BRCA1 shuttling determines cellular susceptibility to DNA damage as augmentation of cytosolic BRCA1 significantly enhances cancer cell susceptibility to ionizing radiation. Taken together, our data suggest that p53 dysfunction compromises nuclear export of wt BRCA1 as a mechanism to increase cellular resistance to DNA damage in sporadic breast cancer. We propose that targeting nuclear BRCA1 to the cytoplasm may offer a unique strategy to sensitize p53-deficient sporadic breast cancers to DNA damage - based therapy.

Original languageEnglish (US)
Pages (from-to)5546-5557
Number of pages12
JournalCancer Research
Volume71
Issue number16
DOIs
StatePublished - Aug 15 2011
Externally publishedYes

Fingerprint

Cell Nucleus Active Transport
DNA Damage
Breast Neoplasms
Cytoplasm
Ionizing Radiation
Protein Binding
Neoplasms
Mutation
Therapeutics
Proteins

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Jiang, J., Yang, E. S., Jiang, G., Nowsheen, S., Wang, H., Wang, T., ... Xia, F. (2011). p53-dependent BRCA1 nuclear export controls cellular susceptibility to DNA damage. Cancer Research, 71(16), 5546-5557. https://doi.org/10.1158/0008-5472.CAN-10-3423

p53-dependent BRCA1 nuclear export controls cellular susceptibility to DNA damage. / Jiang, Juhong; Yang, Eddy S.; Jiang, Guochun; Nowsheen, Somaira; Wang, Hong; Wang, Tong; Wang, Yihan; Billheimer, David D; Chakravarthy, A. Bapsi; Brown, Melissa; Haffty, Bruce; Xia, Fen.

In: Cancer Research, Vol. 71, No. 16, 15.08.2011, p. 5546-5557.

Research output: Contribution to journalArticle

Jiang, J, Yang, ES, Jiang, G, Nowsheen, S, Wang, H, Wang, T, Wang, Y, Billheimer, DD, Chakravarthy, AB, Brown, M, Haffty, B & Xia, F 2011, 'p53-dependent BRCA1 nuclear export controls cellular susceptibility to DNA damage', Cancer Research, vol. 71, no. 16, pp. 5546-5557. https://doi.org/10.1158/0008-5472.CAN-10-3423
Jiang J, Yang ES, Jiang G, Nowsheen S, Wang H, Wang T et al. p53-dependent BRCA1 nuclear export controls cellular susceptibility to DNA damage. Cancer Research. 2011 Aug 15;71(16):5546-5557. https://doi.org/10.1158/0008-5472.CAN-10-3423
Jiang, Juhong ; Yang, Eddy S. ; Jiang, Guochun ; Nowsheen, Somaira ; Wang, Hong ; Wang, Tong ; Wang, Yihan ; Billheimer, David D ; Chakravarthy, A. Bapsi ; Brown, Melissa ; Haffty, Bruce ; Xia, Fen. / p53-dependent BRCA1 nuclear export controls cellular susceptibility to DNA damage. In: Cancer Research. 2011 ; Vol. 71, No. 16. pp. 5546-5557.
@article{e849f50ce2724371a1917d6ae823818a,
title = "p53-dependent BRCA1 nuclear export controls cellular susceptibility to DNA damage",
abstract = "Subcellular localization regulates BRCA1 function, and BRCA1 is exported to the cytoplasm following DNA damage in a p53-dependent manner. Because more than 50{\%} of solid tumors harbor p53 mutations, it is possible that genetically wild-type (wt) BRCA1 is functionally abnormal through compromised nuclear-cytoplasmic shuttling in sporadic breast cancer patients with dysfunctional p53. In this study, we have investigated the mechanisms of p53-dependent BRCA1 subcellular distribution and DNA damage-induced nuclear export, as well as the impact on the resulting cytotoxic response to therapy in human breast cancer. We first show that p53 mediates BRCA1 nuclear export via protein - protein binding, rather than by modulation of its transcription. Furthermore, it is the C-terminal (BRCT) region of BRCA1 that is critical for its interaction with p53, and p53 may promote BRCA1 nuclear export by interrupting the association of BRCA1 with BARD1. In sporadic breast cancer specimens, dysfunctional p53 strongly correlates with nuclear retention of sequence-verified wt BRCA1. This p53-dependent BRCA1 shuttling determines cellular susceptibility to DNA damage as augmentation of cytosolic BRCA1 significantly enhances cancer cell susceptibility to ionizing radiation. Taken together, our data suggest that p53 dysfunction compromises nuclear export of wt BRCA1 as a mechanism to increase cellular resistance to DNA damage in sporadic breast cancer. We propose that targeting nuclear BRCA1 to the cytoplasm may offer a unique strategy to sensitize p53-deficient sporadic breast cancers to DNA damage - based therapy.",
author = "Juhong Jiang and Yang, {Eddy S.} and Guochun Jiang and Somaira Nowsheen and Hong Wang and Tong Wang and Yihan Wang and Billheimer, {David D} and Chakravarthy, {A. Bapsi} and Melissa Brown and Bruce Haffty and Fen Xia",
year = "2011",
month = "8",
day = "15",
doi = "10.1158/0008-5472.CAN-10-3423",
language = "English (US)",
volume = "71",
pages = "5546--5557",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "16",

}

TY - JOUR

T1 - p53-dependent BRCA1 nuclear export controls cellular susceptibility to DNA damage

AU - Jiang, Juhong

AU - Yang, Eddy S.

AU - Jiang, Guochun

AU - Nowsheen, Somaira

AU - Wang, Hong

AU - Wang, Tong

AU - Wang, Yihan

AU - Billheimer, David D

AU - Chakravarthy, A. Bapsi

AU - Brown, Melissa

AU - Haffty, Bruce

AU - Xia, Fen

PY - 2011/8/15

Y1 - 2011/8/15

N2 - Subcellular localization regulates BRCA1 function, and BRCA1 is exported to the cytoplasm following DNA damage in a p53-dependent manner. Because more than 50% of solid tumors harbor p53 mutations, it is possible that genetically wild-type (wt) BRCA1 is functionally abnormal through compromised nuclear-cytoplasmic shuttling in sporadic breast cancer patients with dysfunctional p53. In this study, we have investigated the mechanisms of p53-dependent BRCA1 subcellular distribution and DNA damage-induced nuclear export, as well as the impact on the resulting cytotoxic response to therapy in human breast cancer. We first show that p53 mediates BRCA1 nuclear export via protein - protein binding, rather than by modulation of its transcription. Furthermore, it is the C-terminal (BRCT) region of BRCA1 that is critical for its interaction with p53, and p53 may promote BRCA1 nuclear export by interrupting the association of BRCA1 with BARD1. In sporadic breast cancer specimens, dysfunctional p53 strongly correlates with nuclear retention of sequence-verified wt BRCA1. This p53-dependent BRCA1 shuttling determines cellular susceptibility to DNA damage as augmentation of cytosolic BRCA1 significantly enhances cancer cell susceptibility to ionizing radiation. Taken together, our data suggest that p53 dysfunction compromises nuclear export of wt BRCA1 as a mechanism to increase cellular resistance to DNA damage in sporadic breast cancer. We propose that targeting nuclear BRCA1 to the cytoplasm may offer a unique strategy to sensitize p53-deficient sporadic breast cancers to DNA damage - based therapy.

AB - Subcellular localization regulates BRCA1 function, and BRCA1 is exported to the cytoplasm following DNA damage in a p53-dependent manner. Because more than 50% of solid tumors harbor p53 mutations, it is possible that genetically wild-type (wt) BRCA1 is functionally abnormal through compromised nuclear-cytoplasmic shuttling in sporadic breast cancer patients with dysfunctional p53. In this study, we have investigated the mechanisms of p53-dependent BRCA1 subcellular distribution and DNA damage-induced nuclear export, as well as the impact on the resulting cytotoxic response to therapy in human breast cancer. We first show that p53 mediates BRCA1 nuclear export via protein - protein binding, rather than by modulation of its transcription. Furthermore, it is the C-terminal (BRCT) region of BRCA1 that is critical for its interaction with p53, and p53 may promote BRCA1 nuclear export by interrupting the association of BRCA1 with BARD1. In sporadic breast cancer specimens, dysfunctional p53 strongly correlates with nuclear retention of sequence-verified wt BRCA1. This p53-dependent BRCA1 shuttling determines cellular susceptibility to DNA damage as augmentation of cytosolic BRCA1 significantly enhances cancer cell susceptibility to ionizing radiation. Taken together, our data suggest that p53 dysfunction compromises nuclear export of wt BRCA1 as a mechanism to increase cellular resistance to DNA damage in sporadic breast cancer. We propose that targeting nuclear BRCA1 to the cytoplasm may offer a unique strategy to sensitize p53-deficient sporadic breast cancers to DNA damage - based therapy.

UR - http://www.scopus.com/inward/record.url?scp=80051673613&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051673613&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-10-3423

DO - 10.1158/0008-5472.CAN-10-3423

M3 - Article

C2 - 21742769

AN - SCOPUS:80051673613

VL - 71

SP - 5546

EP - 5557

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 16

ER -